Report copyright - 20190321 - Challenges - Novartis Part 1 · 2019. 3. 26. · de ventes Entresto (insurfisance cardiaque), Promacta (anómie apla- sique sóvère), Xolair et Mekinist (cancer). Il en
Please pass captcha verification before submit form
Please pass captcha verification before submit form